Cerevasc today announced the first-in-human use of its eShunt system to treat medically refractory idiopathic intracranial hypertension (IIH).

Our findings suggest that GLP-1 therapy holds real promise. While a randomized trial is still needed, the fact that many patients with IIH already qualify for GLP-1s due to diabetes or obesity means ...

Spryte Medical announced the commencement of enrollment in the INSYTE trial evaluating the company’s neuro-optical CT (nOCT) ...

Intracranial hypertension (IH), a clinical condition typically seen in the intensive care unit, is caused by increased pressure surrounding the brain. In many situations, the cause of chronic IH is ...

Please provide your email address to receive an email when new articles are posted on . Glaucoma may be a result of two pressures: IOP and intracranial pressure. When one pressure is high and the ...

Among women with idiopathic intracranial hypertension (IIH) and a body mass index (BMI) of 35 or higher, bariatric surgery was a more effective means of reducing intracranial pressure and sustaining ...

Direct oral anticoagulant (DOAC) therapy is not associated with a significantly higher risk for intracranial hemorrhage than single-agent antiplatelet therapy. However, DOACs are linked to an ...

Rising vitamin K refusal rates correlated with later healthcare hesitancy, including higher likelihoods of refusing childhood immunizations.

Intracranial angioplasty again failed for less severe intracranial atherosclerotic stenosis (ICAS) strokes in a Chinese trial. However, a separate analysis did leave a glimmer of hope that IV ...

There are many causes of headaches, from stress to diet to serious medical conditions. Two types of headaches are caused by a change of pressure inside your skull: low-pressure headaches (your doctor ...